Find Academic Supervisors

• Transplantation
• Nephrology
• Diabetes
• +3 more

Professor Philip O'Connell (MBBS, PhD, FAHMS) serves as Executive Director of the Westmead Institute for Medical Research and holds appointments at the University of Sydney's Faculty of Medicine and Health . He is a leading authority in transplantation immunology and renal allograft dysfunction , with major contributions to islet transplantation and transplant biomarker development . Research Themes: His work spans diabetes cure strategies through islet xenotransplantation, genomics of transplant rejection, and ethical solutions to global organ shortages. Current projects include: $3.3M JDRF grant for drug-free islet transplant protocols $1.06M NHMRC grant on renal transplant fibrosis gene pathways $9.46M NHMRC program for type 1 diabetes intervention Publication Trends (2022-2025): Focus on genetic determinants of transplant success (LIMS1, APOL1), machine learning for biopsy analysis, and immunomodulatory strategies (CD47, IL-2, TNFAIP3). Collaborative work with Mount Sinai School of Medicine on transplant biomarkers via NIH funding. Awards: 2018 Fellow, Australian Academy of Health and Medical Sciences 2003 TJ Neale Award for nephrology contributions 1989 Gordon-Taylor Scholarship (University of Melbourne) 2011-2021 NHMRC Senior Practitioner Fellow Leadership: Past President of The Transplantation Society (2014-2016), director of Centre for Transplant and Renal Research, and key member of the Declaration of Istanbul Custodian Group. His lab at Westmead Hospital pioneers pig-to-human xenotransplant models and develops regulatory T cell therapies.

Jason DelborneView profile

Professor

• Science, Technology, and Society (STS)
• Science & Technology Policy
• Genetic Engineering and Society
• +7 more

Jason Delborne is a Professor of Science, Policy, and Society at North Carolina State University's Department of Forestry and Environmental Resources. Holding a Ph.D. from UC Berkeley (2005) and A.B. from Stanford (1993), Dr. Delborne bridges science and policy through interdisciplinary research. Education: A.B., Stanford University (1993) Ph.D., University of California, Berkeley (2005) Research Interests: Dr. Delborne specializes in Science, Technology, and Society (STS), focusing on genetic engineering governance, environmental policy, politicized scientific controversies, and biocontrol ethics. His work integrates social science perspectives with biotechnology applications for sustainable solutions. Grant Activities: He leads projects funded by the US Fish & Wildlife Service ($499,863), NSF ($3.76 million total across grants), and USDA ($25,000). Key grants include: PIPP Phase I: Real-time Analytics for Plant Disease Prediction ($1M NSF grant) NRT-INFEWS: Agricultural Biotechnology in FEW Systems (Lead on $2.99M NSF grant) MAISRC: Genetic Control of Invasive Fish Species (Co-PI on $82,711 grant) US Air Force grant for bioindustrial workforce training Training & Leadership: Dr. Delborne directs the Genetic Engineering and Society (GES) minor, trains STEM graduate students in interdisciplinary approaches, and develops integrated educational platforms for biomanufacturing workforce development.

Vilma LukaševičienėView profile

Lecturer

• Medical Ethics
• Bioethics
• Health Law
• +3 more

Vilma Lukaševičienė is a Lecturer in Medical Ethics at Vilnius University , specifically within the Medical Ethics and History Studies (MIES) faculty's Department of Medical Ethics. She holds a Master of Laws degree and focuses on interdisciplinary research at the intersection of law, medicine, and ethics. Her research interests emphasize international bioethics policy development, regulatory frameworks for clinical trials, and the ethical dimensions of healthcare governance. She actively contributes to teaching medical ethics across disciplines, including courses in medicine, nursing, dentistry, and public health. Lukaševičienė has published in high-impact journals such as the Hastings Center Report and European Journal of Clinical Pharmacology , addressing topics like capacity-building for national bioethics committees and challenges in implementing EU clinical trial regulations. Her work bridges theoretical ethics with practical regulatory challenges in global health systems. No scientific awards have been explicitly noted, though her contributions to bioethics education and policy research are central to her professional profile. She collaborates with colleagues on projects related to bioethics education and regulatory compliance, though specific grants or advising roles are not detailed in the available texts. She is affiliated with the MIES library, contributing to its bioethics bibliography and case analysis resources, which support student training in ethical dilemmas such as transplantation ethics, biomedical research integrity, and end-of-life decision-making.

Nanibaa’ GarrisonView profile

Associate Professor

• Bioethics
• Genomics
• Indigenous Data Sovereignty
• +4 more

Nanibaa’ Garrison is an Associate Professor and Vice Chair of Academic Personnel & Development Initiatives at the University of California, Los Angeles (UCLA). She holds appointments in the Institute for Society and Genetics, Institute for Precision Health, and the Division of General Internal Medicine & Health Services Research. Her primary teaching role is within UCLA’s genetic counseling master’s program. Dr. Garrison earned her PhD in Genetics from Stanford University and completed a postdoctoral fellowship in bioethics at Stanford’s Center for Biomedical Ethics. Her research focuses on ethical, social, and cultural implications of genetic research in Indigenous communities, emphasizing community-based approaches to develop equitable policies and guidance for genomics research. Her work spans interdisciplinary collaborations, addressing topics such as Indigenous data sovereignty, genomic equity, and the integration of Indigenous knowledge systems into research frameworks. Notable contributions include applying the CARE Principles for Indigenous Data Governance to ecological and biomedical research contexts, and advocating for diversity in genomic studies. Selected publications highlight her focus on community engagement, tribal consent models, and addressing underrepresentation in genomics. She has contributed book chapters on evolving consent practices and case studies of Indigenous bioethical challenges, such as the Havasupai Tribe’s legal case against genetic researchers.

Emilian MihailovView profile

Associate Professor

• Applied Ethics
• Moral Philosophy
• Moral Psychology
• +2 more

Emilian Mihailov serves as Associate Professor at the Faculty of Philosophy, University of Bucharest, where he has held progressive academic roles since 2015: Teaching Assistant (2015-2018), Lecturer (2018-2022), and current Associate Professor (2022-present). He concurrently directs the Research Centre in Applied Ethics (2020-present), previously serving as its Executive Director (2013-2020), and held the position of Ethics Office Coordinator at the university (2014-2016). Education: Doctoral degree in Philosophy (SUMMA CUM LAUDE), University of Bucharest (2009-2012) Visiting PhD researcher, Oxford Uehiro Centre for Practical Ethics, University of Oxford (2012) Master Degree in Philosophy, University of Bucharest (2008-2009) Bachelor Degree in Philosophy, University of Bucharest (2004-2008) Research Focus: Mihailov specializes in Applied Ethics, Moral Psychology, and Neuroethics, with particular emphasis on cognitive enhancement technologies, neurotechnological impacts on identity, and Kantian reconstructions of moral theory. His 2017 monograph Arhitectonica moralității reinterprets Kant's ethical framework, while his current exploratory project Ethics of Future Humans develops pluralist evaluation models for bioenhancement technologies. His work consistently bridges theoretical philosophy with empirical bioethics through international collaborations. Publication Trends: Analysis of his 15 most recent publications (2016-2022) reveals three dominant trajectories: (1) Neuroethical investigations of identity/authenticity under technological influence (40% of works), (2) Methodological innovations in empirical bioethics combining philosophical analysis with digital tools (30%), and (3) Kantian applications to contemporary dilemmas in cognitive enhancement and organ donation policy (30%). His scholarship demonstrates systematic integration of moral psychology with practical ethics frameworks. Scientific Awards: No specific prizes, medals, or fellowships are documented in the source material. Grants and Leadership: Mihailov secured significant research funding including Swiss National Foundation support (2015-2017) for bioethics capacity-building across Moldova-Romania-Switzerland, Romanian Academy postdoctoral funding (2014-2015), and Society of Applied Philosophy grants for international workshops (2014). He directs the Research Centre in Applied Ethics, which maintains active partnerships with Oxford Uehiro Centre and Basel's Institute of Biomedical Ethics, coordinating multi-institutional projects and editorial initiatives including The Romanian Journal of Analytic Philosophy (Editor-in-Chief 2013-2016). Academic Engagement: As Director of the Research Centre, he leads collaborative networks with Oxford, Basel, and Tübingen institutions, organizes international workshops (including events with Christine Korsgaard), and contributes to national bioethics policy through parliamentary consultancy. His public scholarship includes 15+ media articles and interviews with leading philosophers like Peter Singer and Julian Savulescu.

Ian SherriffView profile

Professor

• Dementia Care
• Dementia Policy
• Dementia-Friendly Communities
• +12 more

Ian Sherriff is the Academic Partnership Lead for Dementia at the Peninsula Medical School, Faculty of Medicine and Dentistry, University of Plymouth. He is a leading figure in dementia research, policy, and education, with significant national and international influence. His research interests center on dementia care, particularly in rural communities, dementia-friendly environments, air travel for people with dementia, veterans' dementia support, and health systems improvement. His methodological expertise includes realist evaluation, mixed methods, and policy impact research. The recent research articles highlight a strong focus on evaluating person-centred dementia care interventions (D-PACT), stakeholder engagement in theory building, ethical inclusion in dementia research, biomarker research in Alzheimer's disease, and learning communities for dementia care improvement. These works span clinical, ethical, policy, and community-based domains, reflecting a highly interdisciplinary and impactful research program. B.E.M. (Member of the Order of the British Empire) - Queens Birthday Honors List 2019 National Dementia Friendly City Award 2016/2017 Medical Journal National Dementia Team of the Year Plymouth University Ambassador Award 2014 Ian Sherriff has supervised PhD students, notably on dementia and air travel. He has secured major research grants, including for the D-PACT programme and CombiDiag project. He is a keynote speaker at international conferences and has led the development of dementia-friendly initiatives globally, including in Italy and Ukraine. He has established international collaborations and memoranda with institutions in Macau, Japan, and the Netherlands. He is deeply involved in national policy through roles in the Prime Minister's Dementia Champion group, rural dementia task forces, and air transport initiatives. He chairs multiple national and global dementia groups and is a trustee for several veteran support organizations. He is actively involved in teaching and training for a wide range of healthcare professionals, including nurses, medics, paramedics, dentists, midwives, and social care staff, both in the UK and internationally (e.g., China). He has also trained airport, city, and farming network staff in dementia awareness.

Stella NicolaouView profile

Associate Professor

• Immunology
• Food Allergy
• Medical Education
• +2 more

Dr. Stella Nicolaou is an Associate Professor of Immunology at the University of Nicosia , where she serves as the Coordinator of the MSc in Biomedical Sciences Programme (focusing on clinical immunology laboratory science). She also holds an Honorary Senior Lecturer position at St. George's University of London , supervising students in their PgCert in Healthcare and Biomedical Education . Her academic journey includes a BSc in Medical Technology from the University of Indianapolis and a PhD in Pathobiology and Molecular Medicine from the University of Cincinnati. Education: BSc in Medical Technology, University of Indianapolis PhD in Pathobiology and Molecular Medicine, University of Cincinnati PgCert in Healthcare and Biomedical Education (HBE), St. George’s University of London Dr. Nicolaou’s research spans basic and epidemiological studies in food allergies and education research in biomedical sciences . Her work explores the interplay between problem-based learning (PBL) and student motivation , as well as the impact of food allergies on health-related quality of life in Cyprus. She has secured funding from the EU Tempus Programme and Cyprus Research Promotion Foundation (RPF) . Her recent publications highlight trends in medical education and allergy research , with a focus on longitudinal studies in PBL, food allergy epidemiology, and digital adaptations in teaching. These outputs reflect her dual expertise in immunology and pedagogical innovation . Scientific Awards: No specific awards listed in provided texts. Dr. Nicolaou actively mentors students in biomedical sciences and has contributed to curriculum development, including leadership modules for medical education. She serves on the Cyprus National Bioethics Committee and is involved in international collaborations, particularly in anti-doping education projects across Europe.

Liana WoskieView profile

Assistant Professor

• Reproductive Policy
• Health System Performance
• Health Economics
• +4 more

Liana Woskie serves as Assistant Professor in the Department of Community Health at Tufts University's School of Arts and Sciences, with adjunct appointments at Brown University and Harvard T.H. Chan School of Public Health. Her work bridges reproductive policy, health economics, and human rights accountability in healthcare systems. PhD, London School of Economics and Political Science (2023) MSc, London School of Economics & London School of Hygiene and Tropical Medicine BA, Wesleyan University Dr. Woskie's research centers on structural violence in reproductive healthcare, evidenced by her Guggenheim-awarded dissertation on sterilization coercion. She examines health system performance through lenses of gender equity, pandemic response (notably analyzing sex-segregated lockdowns in Panama and India), and pharmaceutical policy. Her work on US health spending with Papanicolas and Jha was designated JAMA's Top Article of the Decade, directly informing Congressional hearings. Her recent publications reveal strong thematic continuity in reproductive justice and health system accountability, with 2025 works dissecting coercion in sterilization practices and abortion access barriers. The scholarship demonstrates methodological diversity spanning legal analysis, epidemiological modeling, and health financing studies across India, Panama, and the European Union. H.F. Guggenheim Emerging Scholar Award for dissertation on structural violence JAMA Top Article of the Decade (2018) NIH BIRCWH career development award (2025) Horowitz Foundation Trustees' Award (2023) Dr. Woskie directs multiple active grants including NIH-funded comparative pharmaceutical policy research and Gates Foundation-supported health system reform in India. Her teaching portfolio features advanced seminars on abortion jurisprudence and reproductive rights, advising senior theses in community health. She previously coordinated the Lancet Ebola Governance Panel and continues pandemic response analysis through mobility data studies.

• Parasitic Zoonoses
• Health Outcomes Research
• Tropical Diseases
• +2 more

Paula Sánchez Thevenet serves as Full Professor in the Department of Medicine and Surgery at the Faculty of Health Sciences, CEU Cardenal Herrera University (UCHCEU), Spain. She concurrently leads the Health Outcomes Research Group (GIRS/CEU) and holds critical institutional roles including Head of Research at the Castellón campus and member of the Committee for Research with Human Subjects. Education: BSc in Biochemistry, National University of Patagonia San Juan Bosco (UNPSJB), Argentina PhD in Biochemistry, National University of Patagonia San Juan Bosco (UNPSJB), Argentina International Master's Degree in Parasitology and Tropical Diseases, University of Valencia, Spain Official Master's Degree in Bioethics, Catholic University of Valencia, Spain Research Focus: Dr. Sánchez Thevenet's pioneering work centers on parasitic zoonoses and health outcomes research (HOR) , with specialized expertise in hydatidosis vaccine development (EG95) and tropical disease control. Her research bridges laboratory science and public health implementation through collaborations with Spain's Instituto de Salud Carlos III (ISCIII) and Argentine institutions. Scientific Recognition: International Association of Hydatology (Argentine Branch) recognition for hydatidosis contributions Argentine Senate honor for scientific impact Gregal de Castellón Prize (2016) CEU-Innova Awards Honorable Mention (2015) Ibero-American GoHa Award (2019) Academic Leadership: With 18 years of prior teaching at UNPSJB (Argentina), she currently instructs Medicine and Nursing students at UCHCEU while supervising doctoral theses across Argentina and CEINDO (CEU). Her eight teaching innovation projects include award-winning initiatives like 'Pixel: People Before Patients' and the Medical Dictionary of Genetics. As former Vice Dean of Health Sciences and current PAHO echinococcosis trainer, she integrates research with global health capacity building. Research Infrastructure: She directs the Health Outcomes Research Group (GIRS/CEU) and maintains active membership in the Spanish Society of Tropical Medicine's Hydatidosis Group, leveraging these platforms for vaccine development and health policy research.

Gregor WolbringView profile

Professor

• Ability Expectation and Ableism Studies
• Disability Studies
• Equity, Diversity and Inclusion
• +9 more

Gregor Wolbring is a Full Professor at the University of Calgary's Faculty of Medicine, within the Community Rehabilitation and Disability Studies Program. He holds concurrent positions as a Fellow at the University of Ottawa's Institute for Science, Society and Policy, a Visiting Professor at the American University of Sovereign Nations, and a Permanent Fellow at the Institute for Technology Assessment and Systems Analysis (ITAS) in Karlsruhe. His academic journey includes a biochemistry degree from the University of Tübingen and University College London (1982-1989), a doctorate from the University of Frankfurt am Main and the Max Planck Institute of Biophysics (1989-1992), and postdoctoral work at the University of Calgary (1992-1998). Wolbring's research is profoundly interdisciplinary, anchored in Ability Expectation and Ableism Studies (Ability Studies) and Disability Studies . His core interests encompass: Technology Assessment & Governance: Social robotics, brain-machine interfaces, nanotechnology, synthetic biology, AI, and human enhancement. Social Justice & Inclusion: Equity, diversity, inclusion (EDI), accessibility, environmental justice (eco-ableism), global health disparities, and human security (food, water, skills). Sustainability & Policy: Climate change, energy policy, water security, and the social dimensions of sustainability. Health & Ethics: Bioethics, health technology assessment, aging well, peace research, and the societal implications of health discourses. His publication record, analyzed collectively, reveals a dominant focus on societal perceptions and governance of emerging technologies (especially assistive tech, AI, neuro-enhancement), critical analyses of media representations concerning disability, aging, health, and global issues, and the development of conceptual frameworks like 'Ability Studies' and 'Eco-ableism'. Methodologically, he frequently employs scoping reviews, content analysis of media/public discourse, and qualitative exploration of lived experiences, consistently applying an equity, justice, and disability rights lens. Wolbring has received significant recognition, including the 2022 University of Calgary Equity, Diversity and Inclusion Award , the 2017 Tanis Doe Award from the Canadian Disability Studies Association, the Queen Elizabeth II Diamond Jubilee Medal (2013) , multiple BHSc Research Mentor Awards , and nominations for graduate supervision awards. He mentors the interdisciplinary undergraduate research team WolbPack , fostering collaborative scholarship on disability, technology, and social justice. He leads the research group 'Health and the Technization of Life' at ITAS and the 'WolbPack' in Calgary. His work emphasizes building student capacity as 'community scholars' and addresses critical gaps in understanding the intersectional realities of disabled people facing environmental crises and technological change.

• Public Health
• Health Promotion
• Nursing Education
• +4 more

Anna Bonmatí Tomàs is an Associate Professor in the Department of Nursing at the University of Girona (UdG) since 2019. She is an active member of the Health and Healthcare Research Group and has coordinated the European Training Consortium Public Health and Health Promotion (ETC-PHHP) since 2016. She also serves on the Florence Network Board (since 2020) and acts as Associate Editor of Global Health Promotion (since 2021). Education Bachelor in Pharmacy, University of Barcelona (1996) Diploma in Nursing, University of Girona (2009) Diploma in Business Sciences, Open University of Catalonia (2014) Doctorate, University of Girona (2016) Master’s in Nutrition & Food, IL3 University of Barcelona Virtual Master’s in Community Pharmaceutical Care, University of Valencia Postgraduate Diploma in Health Management, University of Girona Inter-university Postgraduate Diploma in University Teaching Master’s in Health Promotion, University of Girona Master’s in Bioethics, Ramon Llull University Research Interests Anna Bonmatí Tomàs focuses her research on public health and health promotion , with particular attention to health equity for migrant and minority populations . She investigates salutogenic approaches that strengthen community assets and empower vulnerable groups such as immigrant women and sexual/gender minorities. Additional strands of work include nursing education innovations (especially simulation-based learning and assessment), healthy ageing in place , and digital health literacy during crises such as COVID-19. Interdisciplinary collaboration and cross-border projects are hallmarks of her research portfolio. Across her recent publications she has examined breastfeeding support networks after humanitarian disasters, validated instruments for medication-safety education, evaluated nurse-centred discharge planning, and explored the interplay between nurses’ psychological resources (e.g., optimism, sense of coherence) and occupational wellbeing. These works collectively advance evidence-based practice in both community and clinical settings. Scientific Awards & Distinctions No specific prizes, medals, or fellowships are explicitly listed in the provided material. Research Funding & Teams Anna has been Principal Investigator or team member on multiple competitive grants, including: EU REGIO Cross-Border Centre: Health and Social Training & Research (2009-2012) Generalitat of Catalonia “ENTREPRENEUR” project on women at risk of social exclusion (2012) University of Girona InfCT-2017.05 grant (2017) University of Girona “Health and empowerment of people” (2016-2019) ISCIII PI21/00951 – Digital health literacy intervention for stroke patients during COVID-19 (2022-2024) ISCIII PI21/00508 – Cardiovascular risk in sexual & gender minorities using primary-care records (2022-2024) She leads and collaborates within the Health and Healthcare Research Group at UdG and coordinates the ETC-PHHP , a consortium that organises intensive summer schools across Europe to build capacity in health promotion and public health.

• Neuroethics
• Brain-Computer Interfaces
• Informed Consent
• +6 more

Ashley Feinsinger, Ph.D. is an Assistant Professor in the Department of Neurosurgery at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). She serves as Co-Principal Investigator for multiple NIH-funded research initiatives, including the NeuroEthics of Non-Therapeutic Invasive Human Neurophysiologic Research (NIH RF1MH121373) and as Co-Principal Investigator of Ethics Supplement for the Early Feasibility Clinical Trial of a Visual Cortical Prosthesis (NIH UH3NS103442). Dr. Feinsinger is also a key contributor to the UCLA-CDU Dana Center for Neuroscience and Society as MPI. Role: Assistant Professor, Department of Neurosurgery Institution: University of California, Los Angeles (UCLA) Affiliation: David Geffen School of Medicine Dr. Feinsinger's research focuses on neuroethics, particularly examining ethical challenges in translating brain-computer interfaces and neural implant technologies. Her work addresses critical issues in informed consent processes for intraoperative brain research, post-trial obligations for neural implant studies, and participant perspectives in visual cortical prosthesis trials. She also explores feminist ethics in medical education and bioethical considerations in human intracranial electrophysiology research. Her recent publications (2022-2025) span neuroethics, visual prosthesis development, patient-centered communication for disabled individuals, and psychiatric neurosurgery frameworks. Key themes include ethical frameworks for emerging neurotechnologies, informed consent methodologies, and equitable healthcare practices in organ transplantation contexts. Dr. Feinsinger actively collaborates with researchers across institutions including UCSF (Edward Chang, Winston Chiong), UCLA (Itzhak Fried, Nanthia Suthana), and USC. Her work intersects neuroscience, medical ethics, and human subject research with particular attention to vulnerable populations and technological applications in neurosurgery.

Raina MacIntyreView profile

Professor

• Emerging infectious diseases
• Biosecurity
• Epidemiology
• +8 more

Professor Raina MacIntyre is NHMRC Leadership 3 Fellow and Professor of Global Biosecurity at the University of New South Wales, Faculty of Medicine & Health. She heads the Biosecurity Program at the Kirby Institute, conducting research in epidemiology, bioinformatics, health intelligence, vaccinology, bioterrorism prevention, mathematical modelling, and public health. As of 2024, she is ranked #1 globally on Respiratory Protective Devices and highly ranked in Smallpox research according to Expertscape, with an H-index of 81/64 and over 30,000 citations. Her educational background includes: MBBS (1st Class Honours), University of Sydney, 1988 Master of Applied Epidemiology, Australian National University, 1992 PhD (Epidemiology), Australian National University, 1998 Fellow, Royal Australasian College of Physicians (FRACP), 1994 Fellow, Australian Faculty of Public Health Medicine (FAFPHM), 1995 Professor MacIntyre's research spans four key areas: Personal protective equipment, Vaccinology, Epidemic response and emerging infectious diseases, and bioterrorism prevention. Her innovation, EPIWATCH®, is an advanced AI system for real-time global health intelligence that uses NLP, prioritization algorithms, and LLMs to scan open-source data for early epidemic signals. She has a 31-year track record in pandemics and respiratory virus control, with particular expertise in mask research, having published the largest body of clinical trials on face masks for healthcare workers internationally. Her research publications demonstrate strong focus on emerging infectious disease modeling, vaccine effectiveness, and biosecurity threats. Recent work emphasizes AI-driven health intelligence systems, airborne transmission mitigation, and preparation for re-emergent pathogens like smallpox. Her articles consistently address practical applications of epidemiological research to inform public health policy and emergency response. Professor MacIntyre has received numerous prestigious awards including the Eureka Prize for Leadership and Innovation in Science (2022), the Frank Fenner Award for Research in Infectious Diseases (2003), and the Sir Henry Wellcome Medal and Prize (2007). Her work has been globally recognized, with a quote from her mask research featured on the cover of Lancet in 2020. She currently supervises PhD, ILP, and Masters students in infectious diseases epidemiology and biosecurity. Her research is supported by significant grants including an NHMRC Investigator grant (2023-2027), an MRFF grant for aerosol transmission of SARS-CoV-2, and a $5.39 million gift from Vitalik Buterin's Balvi Philanthropic Fund for EPIWATCH expansion in low and middle-income countries. Professor MacIntyre leads a multidisciplinary team at the Kirby Institute including analysts, epidemiologists, AI specialists, and software engineers developing EPIWATCH® into a global hub for epidemic detection and mitigation. She also co-founded the ARM network for Australian outbreak response and serves on multiple WHO committees including the Technical Advisory Group on COVID-19 Vaccine Composition and the SAGE Ad Hoc Working Group on Smallpox and Monkeypox.

Eric VogelsteinView profile

Associate Professor

• Biomedical Ethics
• Ethical Theory
• Nursing Ethics
• +3 more

Eric Vogelstein serves as an Associate Professor with a joint appointment spanning Duquesne University's School of Nursing and Department of Philosophy within the McAnulty College and Graduate School of Liberal Arts. His dual affiliation uniquely positions him at the intersection of clinical healthcare ethics and philosophical theory, where he has established significant contributions since joining Duquesne in 2013 after completing his PhD at the University of Texas at Austin. His educational trajectory includes a PhD in Philosophy from the University of Texas at Austin (2010), an MA in Philosophy from the University of Colorado at Boulder (2003), and a BA in Philosophy from Brandeis University (2000). This foundation supports his interdisciplinary approach to ethical inquiry. Vogelstein's research program centers on biomedical ethics and ethical theory, with distinctive emphasis on nursing ethics as an autonomous subfield. He critically examines moral expertise in clinical contexts, advance directive validity, surrogate decision-making frameworks, and abortion ethics through both practical case analysis and theoretical innovation. His defense of moral sentimentalism challenges rationalist dominance in metaethics while maintaining clinical relevance. Analysis of his publication record reveals consistent focus on bridging philosophical rigor with healthcare practice. Key trends include increasing attention to nursing-specific ethical dilemmas (2019-2020), refinement of moral expertise concepts (2015-2018), and sustained investigation of advance directives across end-of-life and reproductive contexts. His work spans bioethics, philosophy, and nursing journals, demonstrating cross-disciplinary impact. His scholarly recognition includes: Grefenstette Center Faculty Fellowship (2022-23) Presidential Scholarship Award (2021, 2015) School of Nursing Faculty Award for Excellence in Teaching (2018) While specific grant histories remain undocumented in available sources, his university-funded awards support ongoing research in moral expertise applications and nursing ethics frameworks. His teaching excellence award confirms significant educational contributions to nursing and philosophy students. As an Affiliated Faculty member of Duquesne's Center for Ethics and Policy, Vogelstein participates in institutional ethics initiatives though no dedicated laboratory or research team is specified in current materials.

Roberto GaliziView profile

Academic

• Vector-Borne Diseases
• Genetic Engineering
• Malaria Control
• +3 more

Dr. Roberto Galizi is a Reader in Infectious Diseases at Keele University's School of Life Sciences. He holds a Bachelor’s in Biomedical Technologies from the University of Perugia and a Master’s in Industrial Biotechnology from the University of Urbino. His research focuses on developing genetic technologies to combat vector-borne diseases like malaria through molecular biology approaches. Research interests center on CRISPR-based genetic control of disease vectors, molecular tool development, and insect reproduction studies. His work combines synthetic biology, transcriptomics, and functional genetics to create innovative solutions for malaria eradication. Key scientific contributions include developing gene drive systems for mosquito population control and anti-CRISPR containment strategies. His publications demonstrate a consistent focus on translating genetic technologies into practical vector control applications. Honors include the Marie Curie Fellowship (2014-2016). He leads the Galizi Lab which focuses on capacity building in Mali through the African Centre for Excellence in Molecular Engineering. Teaching includes modules on Molecular Techniques, Case Studies in Biotechnology, and Advanced Topics in Infectious Diseases.